Meyers Kenneth R Form 5 UNITED STATES CELLULAR / KENNETH R MEYERS ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

MEYERS KENNETH R

(Last) (First) (Middle)

8410 WEST BRYN MAWR AVE

(Street)

CHICAGO IL 60631

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES CELLULAR CORP [ USM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
President and CEO

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Shares							2,965(1)	I	By 401k plan
Common Shares							25,771	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Compensation	(2)						(2)	(2)	Common Shares	30,669		30,669(2)	D
Option (Right to Buy)	$39.71						(3)	07/31/2023	Common Shares	125,000		125,000(3)	D
Option (Right to Buy)	$45.87						(4)	04/01/2026	Common Shares	68,766		68,766(4)	D
Performance Share Units	(5)						(5)	(5)	Common Shares	97,013		97,013(5)	D
Performance Share Units	(6)						(6)	(6)	Common Shares	121,818		121,818(6)	D
Performance Share Units	(7)						(7)	(7)	Common Shares	35,396		35,396(7)	D
Restricted Stock Units	(8)						(8)	04/03/2020	Common Shares	75,543		75,543	D
Restricted Stock Units	(8)						(8)	04/02/2021	Common Shares	78,420		78,420	D
Restricted Stock Units	(8)						(8)	04/01/2022	Common Shares	70,791		70,791	D

Explanation of Responses:

1. Voluntary reporting of shares in 401K plan. The information is based on a plan statement dated 12/31/19. The number of shares fluctuates and is attributable to the price of the USM shares on 12/31/19.

2. Reporting person deferred bonuses pursuant to Long Term Incentive Plan. The match vests ratably at 33%, 33%, 34% over a 3 year period, a total of 30,113 are vested.

3. Became exercisable on June 22, 2019

4. Reporting person was granted 206,300 options in 2016. Options vested in annual increments of one-third on April 1 of each year. Reporting person previously exercised 137,534.

5. The 2017 performance share units were granted on April 3, 2017, and become vested on April 3, 2020. The performance period ended on December 31, 2017 with a 128.4% achievement of certain performance measures. The table reports the actual number of shares based on he 128.4% achievement of the performance measures.

6. The 2018 performance share units were granted on April 2, 2018, and become vested on April 2, 2021. The performance period ended on December 31, 2018 with a 155.3% achievement of certain performance measures. The table reports the actual number of shares based on he 155.3% achievement of the performance measures.

7. On April 1, 2019 reporting person was granted an award based on the achievement of certain performance measures, except that such award provides that in no event shall the the number of shares subject to the award be less than 50% of the target opportunity as of the grant date. To the extent that the actual amount is determined to be greater than 50% of the target opportunity based on the final determination of the performance measures, the reporting person will file a Form 4 at such time to report the additional award above the 50% of the target opportunity.

8. Restricted stock units that become vested on the third annual anniversary

Remarks:

	Julie D. Mathews, by power of atty	01/15/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.